NCODA
Empowering medically integrated oncology teams with accreditation, standards, and resources for optimal oral oncolytic care.
Known For
First/only accreditation for medically integrated oncology pharmacies
Key Differentiators
- First/only accreditation for medically integrated oncology pharmacies
- ASCO/NCODA quality standards published in JCO
- focus on MIP model excluding PBM mail-order via OOLD advocacy
- global network with 13k+ members/3k+ sites
Overview
NCODA (National Community Oncology Dispensing Association / Network for Collaborative Oncology Development & Advancement) is a nonprofit organization supporting medically integrated oncology pharmacies (MIPs) embedded in cancer care teams. It provides accreditation, quality standards (co-developed with ASCO), educational resources, best practices, tools for patient management/financial assistance, and advocacy to optimize oral oncolytic dispensing, adherence, and outcomes. Focuses on multidisciplinary oncology teams including pharmacists, physicians, nurses, and administrators to reduce waste, costs, and improve patient-centered care.
Services & Capabilities
- Center of Excellence Medically Integrated Pharmacy (CoE MIP) Accreditation (oncology, multi-specialty, oncology-focus)
- Canadian Pharmacy Accreditation Services (CPAS)
- quality standards/best practices (ASCO/NCODA)
- accreditation templates/training/support
- membership with CE, resources/tools (OCE s
Competitive Position
- First/only accreditation for medically integrated oncology pharmacies
- ASCO/NCODA quality standards published in JCO
- focus on MIP model excluding PBM mail-order via OOLD advocacy
- global network with 13k+ members/3k+ sites
Recent Developments
2026: Appointed four new Executive Council members (Feb); Hosted Inaugural Global Oncology & Haematology Congress (Mar); CMS Medicare Advantage updates, advocacy against step edits; 2025: Announced “Oncology Optimized Limited Distribution” initiative (May); 2025 Fall Summit in Orlando celebrating 10 years; PM360 PharmaChoice Silver Award for Oncolo…
Client & Partner Ecosystem
ASCO (co-developed standards); Prime Therapeutics (preferred accreditation); practice members: American Oncology Network (AON), Nebraska Cancer Specialists, Oklahoma Cancer Specialists, Beacon Cancer ; Oncology practices/sites: Florida Cancer Specialists & Research Institute, MD An; Industry: Genentech, ZS Associates; Partners: Oncology Nursing Society, HOPA, ACCC, NMDP, Prevent Cancer Foundation
Technology Platform
Cost Avoidance Waste Tracker; Legislation Tracker; NCODA CONNECT; PQI Podcast platform
Therapeutic Focus
oncology
Target Customers
oncology practices, medically integrated pharmacies (MIPs), cancer centers/hospitals, oncology professionals (pharmacists, physicians, nurses, APPs, administrators), students
Sources
Similar Vendors
100ms
Voice AI agents automating patient access workflows for pharma and specialty pharmacy to cut delays and boost adherence.
Accessia Health
Nonprofit providing comprehensive financial aid, case management, and legal support to rare/chronic disease patients beyond copays.
AccessSync
Integrated platform unifies payer data and tools to empower biopharma field teams for precise market access execution.
Accreditation Commission for Health Care
Nationally recognized accreditation empowering healthcare providers with quality standards, education, and CMS compliance for excellence.
Agadia Systems
AI-powered utilization management platform automating prior authorization for 100M+ covered lives across 55+ health plan and PBM customers, with an emerging specialty drug ePA portal for pharma.
Apollo Care
Tech-driven copay, hub, and analytics solutions optimizing pharma patient access and commercial performance.